FDA approves Novartis' Flucelvax

FDA approved seasonal influenza vaccine Flucelvax from Novartis AG (NYSE:NVS; SIX:NOVN) to prevent influenza subtypes A and type B in adults. Flucelvax is the first seasonal influenza vaccine approved...